Top compounds associated with response to GRAMD1C


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.6
mRNA hyperforin CTRPv2 pan-cancer AAC 0.018 0.7
mRNA WZ-1-84 GDSC1000 pan-cancer AAC 0.024 0.7
mRNA Cyclopamine GDSC1000 pan-cancer AAC -0.024 0.7
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.016 0.7
mRNA Irinotecan FIMM pan-cancer AAC -0.063 0.7
mRNA BIBR-1532 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA CIL55 CTRPv2 pan-cancer AAC 0.028 0.7
mRNA L-685458 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA Bexarotene FIMM pan-cancer AAC -0.084 0.7
Download CSV